SRIT India Limited delivered a 30.23% return on equity in FY2026 — a capital efficiency figure that exceeds every listed peer cited in its own IPO filing, including Mastek Limited (14.81%), Railtel Corporation of India (16.25%), Protean eGov Technologies (9.69%), Allied Digital Services (5.85%), and Aurionpro Solutions (13.06%) — and the SRIT India IPO, opening September 28, 2026, gives public market investors their first opportunity to buy into this Bengaluru IT solutions company at a P/E of approximately 13.73x.
That 30% ROE on a ₹462.54 crore revenue base, achieved through a combination of healthcare IT, e-governance, and telecom solutions contracts, positions SRIT India differently from the generic enterprise software narrative — this is a vertically focused ITeS company with defensible healthcare IT and government technology relationships.
This article covers the confirmed issue details, SRIT India’s IT business across its core verticals, the three-year financial trajectory, the valuation picture against listed peers, use of proceeds, GMP signal, and what investors should examine before bidding closes September 30.
SRIT India IPO: Who Is SRIT India Limited and What IT Solutions Does It Actually Deliver?
SRIT India Limited is a Bengaluru-based IT solutions and ITeS company operating from its registered office at SRIT House, #113/1B, ITPL Main Road, Kundalahalli — positioned in the heart of Bengaluru’s information technology corridor, adjacent to the International Tech Park Bengaluru.
The company delivers enterprise software and digital transformation solutions across three primary verticals: healthcare IT, e-governance, and telecom and broadband solutions.
In healthcare IT, SRIT India develops and deploys Hospital Management Information System (HMIS) platforms, Hospital Information System (HIS) products, and Electronic Medical Record (EMR) systems. These digital healthcare solutions serve hospital chains, multi-specialty clinics, and government health departments requiring integrated patient record management, billing, pharmacy, and clinical workflow automation.
The e-governance vertical covers government technology contracts — digital platforms for public service delivery, state-level departmental software, and system integration work for central and state government agencies seeking to automate compliance, records, and citizen-facing services.
The telecom and broadband solutions segment addresses telecom operators and internet service providers with technology platforms for network management, subscriber management, and broadband infrastructure operations.
The promoters are Nambiar Raghavan Madhusoodan, Prasaktha Vakkiyl Nambiar, and Martin Poovakkulam Chacko. Their names indicate Kerala origins, consistent with several prominent IT services firms from the Kerala diaspora operating out of Bengaluru.
Choice Capital Advisors Pvt. Ltd. serves as the sole lead manager for this issue, and KFin Technologies Ltd. handles the registrar function — accessible at ipostatus.kfintech.com for allotment status tracking.
SRIT India IPO Dates, Price Band and Full Issue Structure
The SRIT India IPO opens for public subscription on September 28, 2026, and closes on September 30, 2026, with anchor investor bidding on September 25, 2026.
Confirmed Issue Details:
| Event | Detail |
|---|---|
| IPO Open Date | September 28, 2026 |
| IPO Close Date | September 30, 2026 |
| Anchor Bidding Date | September 25, 2026 |
| Allotment Date | October 1, 2026 |
| Refunds / Demat Credit | October 5, 2026 |
| Listing Date | October 6, 2026 (BSE & NSE) |
| Price Band | ₹123 – ₹130 per share |
| Face Value | ₹5 per equity share |
| Issue Size | ~₹218.40 crores |
| Fresh Issue | ~₹218.40 crores (100% fresh, zero OFS) |
| Issue Type | Book Build — Mainboard |
| Listing | BSE & NSE |
The minimum retail application requires 115 shares at ₹14,950 per lot at the upper band of ₹130.
Market Lot Structure:
| Category | Lots | Shares | Amount (₹130) |
|---|---|---|---|
| Retail Minimum | 1 | 115 | ₹14,950 |
| Retail Maximum | 13 | 1,495 | ₹1,94,350 |
| S-HNI Minimum | 14 | 1,610 | ₹2,09,300 |
| S-HNI Maximum | 66 | 7,590 | ₹9,86,700 |
| B-HNI Minimum | 67 | 7,705 | ₹10,01,650 |
The investor allocation follows SEBI’s standard mainboard structure: 50% to Qualified Institutional Buyers (QIB), 15% to Non-Institutional Investors (NII/HNI), and 35% to Retail Individual Investors (RII). The allotment date is October 1, 2026, with demat credits and refunds on October 5, 2026.
SRIT India IPO Financials: Three Years of Compounding Revenue and Returns
The SRIT India IPO financial disclosures show a company that compounded revenue and profit simultaneously over three years — without the lumpy recognition patterns of real estate or the cyclical swings of brokerage.
Consolidated Financials (₹ in Crores):
| Period | Revenue | Expenses | PAT | Total Assets |
|---|---|---|---|---|
| FY2024 | ₹282.22 | ₹243.88 | ₹29.08 | ₹428.96 |
| FY2025 | ₹400.50 | ₹354.31 | ₹33.60 | ₹496.64 |
| FY2026 | ₹462.54 | ₹407.59 | ₹43.29 | ₹614.16 |
Revenue grew 41.9% from FY2024 to FY2025 — driven by scaling healthcare IT and e-governance contracts — then continued at a more measured 15.5% from FY2025 to FY2026 as the company moved toward larger, longer-cycle government and hospital system integration projects.
PAT improved from ₹29.08 crore in FY2024 to ₹43.29 crore in FY2026 — a 48.8% increase over two years — with the acceleration visible in FY2026 (+28.8% year-on-year) outpacing the revenue growth rate of 15.5%, confirming margin expansion rather than just top-line scaling.
Total assets grew from ₹428.96 crore to ₹614.16 crore — a 43.2% increase over the period — reflecting the receivables base expansion and infrastructure investment consistent with a services company winning larger government and healthcare system contracts.
FY2026 Valuation Metrics:
- EPS (Basic): ₹9.47
- NAV per share: ₹40.71
- ROE: 30.23%
- ROCE: 28.79%
- EBITDA Margin: 14.39%
- PAT Margin: 9.62%
- Debt-to-equity: 0.23
- Implied P/E at ₹130 upper band: approximately 13.73x
The debt-to-equity of 0.23 signals a conservatively leveraged balance sheet — appropriate for a government and healthcare IT contractor whose payment cycles can be long and revenue recognition timing tied to project milestones.
SRIT India IPO Use of Proceeds: Working Capital, Capex and the Acquisition Pipeline
Three specific purposes capture the ₹218.40 crore raised through the fresh issue, with the split revealing clear priorities.
Use of Proceeds:
| Purpose | Amount (₹ Crores) |
|---|---|
| Capital expenditure — modernisation of existing products and redevelopment | ₹15.36 |
| Working capital requirements | ₹124.00 |
| Inorganic growth through acquisitions and general corporate purposes | Balance (~₹79 crores) |
The ₹124 crore working capital allocation — 56.8% of total proceeds — reflects the receivables-heavy nature of government and healthcare IT contracts. Government technology and e-governance contracts typically involve extended payment cycles (90-180 days), requiring the company to fund project costs from its own balance sheet before receiving payment.
The ₹15.36 crore capex for product modernisation and redevelopment covers the cost of upgrading existing HMIS, HIS, and telecom platforms to next-generation architectures — including AI-driven solutions integration, cloud migration of legacy healthcare IT systems, and Electronic Medical Record platform redevelopment for newer hospital chain requirements.
The balance toward acquisitions leaves approximately ₹79 crore available for bolt-on purchases in healthcare IT or e-governance software firms — a strategic optionality that government IT contractors often use to acquire smaller domain-specific technology solutions rather than building from scratch.
The 100% fresh issue structure means no selling shareholders take proceeds — all capital enters SRIT India’s balance sheet. Retail investors comparing this with the same-week listings from other verticals can read the Shah Investor’s Home IPO analysis on ipocontrol.in for a contrasting financial services sector IPO that also opens September 28 with a 100% fresh issue structure.
SRIT India IPO vs Listed IT and Government Tech Peers: Where the 30% ROE Puts It
The table below positions the SRIT India IPO against five listed IT solutions and government technology companies that the company’s own filing identifies as peer comparables:
| Company | EPS (₹) | P/E Ratio | RoNW % | NAV (₹) | Revenue (₹ Cr) |
|---|---|---|---|---|---|
| SRIT India Ltd (IPO) | ₹9.47 | ~13.73x (at ₹130) | 30.23% | ₹40.71 | ₹462.54 |
| Mastek Limited | ₹130.45 | 12.59x | 14.81% | ₹965.11 | ₹36,987.50 |
| Railtel Corp of India | ₹10.79 | 24.03x | 16.25% | ₹70.47 | ₹42,774.80 |
| Protean eGov Technologies | ₹24.70 | 19.80x | 9.69% | ₹265.23 | ₹9,977.50 |
| Allied Digital Services | ₹6.30 | 15.52x | 5.85% | ₹21.71 | ₹9,679.10 |
| Aurionpro Solutions | ₹38.90 | 18.62x | 13.06% | ₹322.90 | ₹1,410.85 |
SRIT India enters at approximately 13.73x trailing P/E — cheaper than Railtel (24.03x), Protean eGov (19.80x), Aurionpro (18.62x), and Allied Digital (15.52x). The only peer with a lower P/E is Mastek (12.59x), which operates at ₹36,987 crore revenue — roughly 80 times SRIT India’s scale.
The ROE picture is where SRIT India’s competitive positioning becomes most visible. At 30.23%, its capital returns outperform every named peer — including Railtel (16.25%), Mastek (14.81%), Aurionpro (13.06%), Protean eGov (9.69%), and Allied Digital (5.85%). This ROE profile at a P/E discount to most peers represents the central valuation argument for the SRIT India IPO.
Revenue scale remains the honest counterpoint: ₹462.54 crore versus Railtel’s ₹42,774 crore or Protean’s ₹9,977 crore. SRIT India’s higher ROE and lower P/E reflect both genuine operational efficiency and the smaller-company discount that applies until institutional coverage and revenue scale develop post-listing.
SRIT India IPO GMP Today and What Subscription Signals to Watch
The SRIT India IPO GMP stands at ₹12 per share, implying an expected listing price of approximately ₹142 at the upper band — a 9.2% premium above the ₹130 issue price.
A GMP of ₹12 on a ₹218 crore IT solutions IPO is a constructive positive signal. IT sector IPOs with strong ROE metrics, government-contract visibility, and healthcare IT exposure have consistently attracted quality anchor demand in the FY2025-FY2026 primary market cycle — and a high-quality anchor book typically sustains listing premiums even in moderate subscription windows.
Subscription status across QIB (50%), NII (15%), and RII (35%) categories will update in real time during September 28-30 on nseindia.com and bseindia.com under the IPO section.
The full RHP with audited financials, government contract risk factors, client concentration disclosures, and complete use-of-proceeds breakdown is available at sebi.gov.in. Subscription and listing day news appears on Moneycontrol and Economic Times Markets through the October 6 listing date.
SRIT India IPO Review: Strengths to Note and Risks to Verify
Structural Strengths:
SRIT India’s three-vertical exposure — healthcare IT (HMIS, HIS, EMR), government technology (digital transformation, e-governance), and telecom solutions (broadband platform software) — addresses segments where India’s government-driven digitalisation agenda creates multi-year contract visibility.
The EBITDA margin of 14.39% and PAT margin of 9.62% sit well within the range of quality mid-tier Indian IT services companies, confirming that SRIT India charges for domain expertise rather than competing on commodity rates.
Zero offer for sale means the promoter group takes no liquidity from this IPO — consistent with founder commitment and the deployment of public capital into genuine working capital and product modernisation rather than insider monetisation.
Risks to Examine in the RHP:
Government technology and e-governance contracts carry execution risk — project timelines can extend, payment cycles remain long, and political transitions occasionally pause or restart digital infrastructure projects.
Healthcare IT contract concentration — if a few large hospital chains or state health missions represent a significant share of HMIS/HIS revenue, any client loss or contract renegotiation creates disproportionate revenue impact.
The unidentified acquisitions allocation (~₹79 crore) gives management flexibility that investors cannot underwrite at the IPO stage. Any future acquisition carries integration risk and dilution potential if funded through equity rather than cash.
Frequently Asked Questions
Q1: What does SRIT India actually sell, and how does it differ from a generic IT services company? SRIT India Limited focuses on three defined verticals: healthcare IT (Hospital Management Information System, Hospital Information System, and Electronic Medical Record platforms), e-governance (government technology software and system integration), and telecom and broadband solutions. Unlike pure-play IT staffing or offshore development firms, SRIT India builds and maintains domain-specific digital platforms — making its revenue stickier and its client relationships longer-cycle than project-based IT services companies.
Q2: Can retail investors apply to the SRIT India IPO — and what is the minimum investment? Yes — retail investors can apply through UPI ASBA on any SEBI-registered broker platform from September 28, 2026. The minimum application is 1 lot of 115 shares at ₹14,950 at the upper band of ₹130 per share. The retail maximum is 13 lots (1,495 shares) at ₹1,94,350. Retail Individual Investors (RII) receive 35% of the issue allocation.
Q3: How significant is the 30.23% ROE for SRIT India compared to listed peers? The 30.23% ROE positions SRIT India as the most capital-efficient company among all five peers listed in the company’s own IPO comparison table. Railtel Corporation (16.25%), Mastek (14.81%), Aurionpro (13.06%), Protean eGov (9.69%), and Allied Digital (5.85%) all deliver lower returns on equity. For an IT solutions company in the government and healthcare verticals — segments that typically carry long payment cycles — a 30% ROE indicates either superior contract margins, asset-light delivery, or exceptional receivables management relative to peers.
Q4: Why does working capital need ₹124 crore — more than half the IPO proceeds? Government technology and healthcare IT contracts require upfront delivery before payment, creating a structural working capital deficit. Project execution often begins 60-90 days before milestone payments arrive, and government departments can extend this cycle further through audit or approval processes. SRIT India’s ₹124 crore working capital allocation funds this gap as it scales contract volumes — essentially allowing the company to take on larger government and hospital system integration projects without straining operational cash flow.
Q5: When does allotment happen, and how does an investor check allotment status after applying? The SRIT India IPO allotment date is October 1, 2026. Investors can check allotment status from that date using the KFin Technologies registrar portal at ipostatus.kfintech.com by entering their PAN number or application reference number. Refunds for unsuccessful allotments and demat credits for allotted shares both process on October 5, 2026. The stock lists on BSE and NSE on October 6, 2026.
The Short Verdict on SRIT India IPO at ₹130
The SRIT India IPO makes a coherent investment case through three compounding strengths that appear together infrequently in the Indian midcap IT sector: a 30%+ ROE that beats every listed peer, a P/E of ~13.73x that sits below most comparable government and enterprise IT companies, and three consecutive years of positive PAT growth without a cyclical interruption.
The working capital-heavy use of proceeds reflects the honest operational reality of serving government departments and hospital systems — not a financial engineering choice — and the zero-OFS structure confirms management is building rather than exiting.
The risk to price properly is the revenue scale gap versus listed peers, the government contract payment cycle risk, and the undisclosed promoter holding percentages in the RHP. Investors comfortable with a growing mid-cap IT company in high-visibility government and healthcare verticals — and who read the complete RHP at sebi.gov.in for client concentration and related-party disclosures — will find the SRIT India IPO one of the more fundamentally grounded IT listings of the September-October 2026 primary market window.
Disclaimer: This article is educational and informational only. It does not constitute investment advice or a recommendation to buy, sell, or hold any security. This site is not registered with SEBI as an investment advisor. Consult a SEBI-registered financial advisor before making any investment decisions.